PRSS37 Inhibitors
PRSS37 inhibitors pertain to a specialized classification of chemical compounds that are designed to interact selectively with the protease serine 37 (PRSS37) enzyme. PRSS37 is a serine protease, which is a type of enzyme characterized by its reliance on a serine residue at its active site to perform catalysis. This class of inhibitors is structured to bind with PRSS37, thereby affecting its enzymatic activity. The mechanism of inhibition typically involves the formation of a complex between the inhibitor and the enzyme, which can act to block the substrate's access to the enzyme's active site, alter the enzyme's configuration, or compete with the substrate for binding, depending on the nature of the inhibitor. This interaction is highly specific, as PRSS37 inhibitors are designed to exhibit high affinity and selectivity for PRSS37, with minimal interaction with other serine proteases or off-target effects. The specificity is paramount, considering the vast family of serine proteases, each with its unique physiological roles.
The chemical makeup of PRSS37 inhibitors is diverse, with various inhibitors having different structures and properties. Their design is often informed by the detailed knowledge of the PRSS37 enzyme's structure, particularly the configuration of its active site. Scientists utilize techniques such as X-ray crystallography or NMR spectroscopy to elucidate the three-dimensional structure of PRSS37, which then informs the design of molecules that can fit into or interact with the active site with high specificity. The inhibitors may act as mimics of the natural substrates, but with modifications that prevent catalysis, or they might be entirely different in structure, designed to bind to allosteric sites-locations on the enzyme other than the active site-to induce a conformational change that reduces the enzyme's activity. The development of PRSS37 inhibitors involves a combination of computational modeling, medicinal chemistry, and iterative bioassays to refine their potency and selectivity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $65.00 $122.00 $428.00 $851.00 $1873.00 $4994.00 | 33 | |
Irreversible serine protease inhibitor that covalently modifies the active site, thereby potentially inhibiting the proteolytic activity of PRSS37, which is a serine protease. | ||||||
Nafamostat mesylate | 82956-11-4 | sc-201307 sc-201307A | 10 mg 50 mg | $82.00 $306.00 | 4 | |
A serine protease inhibitor that inhibits the enzymatic activity by forming a stable complex with the enzyme, which could also inhibit PRSS37 by blocking its active site. | ||||||
Gabexate mesylate | 56974-61-9 | sc-215066 | 5 mg | $100.00 | ||
Potent serine protease inhibitor that could inhibit PRSS37 by binding to its active serine site, thus preventing substrate access and processing. | ||||||
Camostat mesylate | 59721-29-8 | sc-203867 sc-203867A sc-203867B sc-203867C sc-203867D sc-203867E | 10 mg 50 mg 500 mg 1 g 10 g 100 g | $43.00 $183.00 $312.00 $624.00 $2081.00 $4474.00 | 5 | |
A synthetic serine protease inhibitor, which might inhibit PRSS37 by occupying the active site and preventing the hydrolysis of peptide bonds. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
A protease inhibitor that targets serine and cysteine proteases and could inhibit PRSS37 by binding reversibly to the active site. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
An irreversible cysteine protease inhibitor that might indirectly inhibit PRSS37 by modifying the protease network and reducing the cleavage of PRSS37 substrates. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
A small protein protease inhibitor that forms reversible complexes with and blocks the active sites of several enzyme proteases, which could lead to the inhibition of PRSS37 activity. | ||||||
Benzamidine | 618-39-3 | sc-233933 | 10 g | $292.00 | 1 | |
A reversible competitive inhibitor of many serine proteases that could inhibit PRSS37 by mimicking the structure of the substrates and binding to the active site. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
A broad-spectrum metalloprotease inhibitor that could restrict the proteolytic network involving PRSS37, potentially reducing its functional activity. | ||||||
Phosphoramidon | 119942-99-3 | sc-201283 sc-201283A | 5 mg 25 mg | $199.00 $632.00 | 8 | |
A metalloprotease inhibitor that might indirectly affect PRSS37 activity by altering the proteolytic environment that PRSS37 operates in. | ||||||